Tim Jasper Knotnerus

Insider Reports History

Location
Antwerpen
Signature
/s/ Ellen Lefever, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tim Jasper Knotnerus:

Company Role Class Num Shares Value Price $ Report Date Ownership
Agomab Therapeutics NV Chief Executive Officer, Director Common shares 34,394 18 Mar 2026 By TJK Life Sciences B.V.
Agomab Therapeutics NV Chief Executive Officer, Director Common shares 10,823 18 Mar 2026 Direct

Insider Reports Filed by Tim Jasper Knotnerus

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AGMB Agomab Therapeutics NV 18 Mar 2026 0 $0 3 Chief Executive Officer, Director 18 Mar 2026, 16:01